Diagnostic biosensors and in vivo bioluminescence imaging model for Alzheimer’s disease – SENS-AD

Despite significant progress made towards understanding the pathophysiology of Alzheimer’s disease, only few efficient treatments are currently available. Early diagnosis for this disease is also a challenge. This project aims to investigate the phenomenon that are known to occur before the cognitive symptoms, such as the aggregation of pathological proteins (such as tau protein) to develop sensitive biosensors which can be applied to the development of new diagnosis tests and as therapeutic targets of new drugs to stop disease progression.